Nonalcoholic fatty liver disease (NAFLD) has been shown to be linked to inflammatory
bowel disease (IBD) due to established risk factors such as obesity, age, and type 2 …

Inflammatory bowel diseases [IBD] exhibit intestinal and systemic manifestations.
Nonalcoholic fatty liver disease [NAFLD] is a common co-existing condition, possibly …

Emerging data have highlighted the co-existence of non-alcoholic fatty liver disease
(NAFLD) and inflammatory bowel disease; both of which are increasingly prevalent …

Non-alcoholic fatty liver disease (NAFLD) is currently considered the most common cause of
liver disease. Its prevalence is increasing in parallel with the obesity and type 2 diabetes …

Methods This longitudinal nationwide cohort study investigated the risk of IBD in patients
with NAFLD alone. General characteristics, comorbidities, and incidence of IBD were also …

Background Epidemiological studies have demonstrated an association between
inflammatory bowel disease (IBD) and an increased risk for the development of nonalcoholic …

Background Nonalcoholic fatty liver disease (NAFLD) has been increasingly identified in
patients with inflammatory bowel disease (IBD). We aimed to determine risk factors of …

Inflammatory bowel diseases (IBD), comprising Crohn's disease and ulcerative colitis, are
systemic and multifaceted disorders which affect other organs in addition to the …

BACKGROUND Nonalcoholic fatty liver disease (NAFLD) is a frequently reported condition
in patients with inflammatory bowel disease (IBD). Both intestinal inflammation and …

Background Nonalcoholic fatty liver disease (NAFLD) is common in inflammatory bowel
diseases (IBD). Herein, NAFLD prevalence and risk factors in a large IBD cohort were …